In trauma patients, TEG® and ROTEM® allow prediction of massive transfusion requirement and mortality, and creation of goal-directed, individualized coagulation algorithms that may improve patient outcome. This outcome benefit has been shown for cardiac surgery in prospective randomized trials. For trauma, only non-randomized studies have been performed. Nevertheless, TEG® and ROTEM® are highly promising monitoring techniques to guide coagulation management in all types of major bleeding, including trauma.
CITATION STYLE
Spahn, D. R. (2014, November 24). TEG®- or ROTEM®-based individualized goal-directed coagulation algorithms: Don’t wait - act now! Critical Care. BioMed Central Ltd. https://doi.org/10.1186/s13054-014-0637-3
Mendeley helps you to discover research relevant for your work.